InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Keutzer Timothy, Directeur du Développement. Director active across 1 companies, notably Spero Therapeutics, Inc.. Aggregated, 4 filings have been published. The latest transaction was filed on 1 February 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
038,014 shares0
Common Stock
SEC:0000899243-22-004589·
038,014 shares0
Common Stock
SEC:0000899243-22-004589:0·
024,067 shares0
Common Stock
SEC:0000899243-21-034499·
024,067 shares0
Common Stock
SEC:0000899243-21-034499:0·
4 of 4 declarations
About Keutzer Timothy
Keutzer Timothy is the Chief Development Officer at Spero Therapeutics, Inc. He is responsible for managing development initiatives and the company's growth strategy. His role is essential to ensure that Spero achieves its objectives in developing new treatments.
